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Abstract
A previously engineered Methanocaldococcus jannaschii tRNA
Tyr
CUA–tyrosyl-tRNA synthetase pair orthogonal to Escherichia
coli was modified to become orthogonal in mammalian cells. The resulting tRNA
Tyr
CUA-tyrosyl-tRNA synthetase pair was able
to suppress an amber codon in the green fluorescent protein, GFP, and in a foldon protein in mammalian cells. The
methodology reported here will allow rapid transformation of the much larger collection of existing tyrosyl-tRNA
synthetases that were already evolved for the incorporation of an array of over 50 unnatural amino acids into proteins in
Escherichia coli into proteins in mammalian cells. Thus we will be able to introduce a large array of possibilities for protein
modifications in mammalian cells.
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Introduction
There are several different approaches for proteins bearing post-
translational modifications. Approaches that make use of expres-
sion vectors with classical molecular biology tools for the in-vivo
expression of proteins are limited to the repertoire of the 20
natural amino acids. Of the 20 natural amino acids, only cysteines
(thiol groups) and lysines (amino groups), both of which can be
specifically reacted with maleimide or active esters, are used for
further protein modifications. However, coupling to natural amino
acids occurs at random sites, since multiple target sites usually exist
in a protein. In an attempt to overcome this challenge, Yanagawa
et al. reported a method for C-teminus specific fluorescence
labeling of proteins by using puromycin derivatives [1].
The incorporation of unnatural amino acids (UAAs) affords
orthogonal chemistry that will occur only with the UAA. Such
incorporation can be achieved via protein chemical synthesis or
semi-synthesis, since both approaches allow for the site-specific
chemical incorporation of UAAs. Both approaches are, however,
limited by the size of the synthesized protein and sometimes even
(in the case of semi-synthetic approach) in the location of UAA
insertion.
Most proteins undergo post-translational modifications and/or
bind a cofactor so as to extend their functional properties. Such
considerations render protein study extremely challenging. Thus,
site-specific incorporation of unnatural amino acids with desired
chemical and physical properties into proteins offers a very useful
research tool to not only facilitate the study of proteins but also to
generate proteins with novel functions [2]. Modifying proteins in
mammalian cells co- and post-translationally is of great impor-
tance both for in vivo as well as for in vitro studies of proteins in
cellular mechanisms. Hence, the incorporation of pre-modified
unnatural amino acids into mammalian proteins has the potential
to greatly assist in such endeavors. Our goal is to create a novel
genetic code(s) in mammalian cells that will allow the site-specific
incorporation of unnatural amino acids into proteins. Technolo-
gies to expand the genetic code have already been developed in
Escherichia coli (E. coli) [3], yeast [2,4,5] and mammalian cells
[6–10]. However, existing methodologies for the creation of
tRNA-aminoacyl-tRNA synthetase pairs for mammalian cells are
not efficient, due to the complicated process of evolving tRNA
synthetases that recognize unnatural amino acids [6–8]. These
methods all require for a tRNA synthetase to have evolved to
recognize an unnatural amino acid and discriminate against the
natural amino acid, which may be very challenging.
In the following report on an approach that enables us to exploit
a large (.50) set of already evolved Methanocaldococcus jannaschii (M.
jannaschii) tRNA synthetases in E. coli [2,4] in order to incorporate
unnatural amino acids into proteins in mammalian cells, thus
alleviating the need for the in vitro evolution of the entire set of
tRNA synthetases in mammalian cells. For an imported tRNA-
synthetase pair to be successfully utilized in a given organism, it
must retain its orthogonality, namely, it must be ensured that none
of the tRNA synthetases of the host organism can aminoacylate
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will be amino-acylated by the introduced aminoacyl-tRNA
synthetase. We report for the first time on a ‘cut and paste’
approach that allows one to transform both a mutant M. jannaschii
tyrosyl-tRNA synthetase and a mutant M. jannaschii tRNA
Tyr
orthogonal to the translational machinery of E. coli for use in the
site-specific suppression of an amber nonsense codon in genes
encoding the green fluorescent protein (GFP) and the foldon
protein, both expressed in mammalian cells.
To date and to the best of our knowledge, there are presently
four known methodologies to site-specifically incorporate unnat-
ural amino acids into proteins in mammalian cells [6–10]. The
first takes advantage of a chemically amino-acylated suppressor
tRNA, micro-electroporated into mammalian cells, yet is limited
by the small amount of protein translated [9]. The second method
utilizes an orthogonal tRNA-aminoacyl-tRNA synthetase to site-
specifically incorporate unnatural amino acids into a protein. The
aminoacyl-tRNA synthetase (RS) is engineered to recognize
unnatural amino acids by mutating the active site, based on a
known structure [6,7]. A third approach involves the transplant of
a previously evolved tRNA synthetase from E. coli and tRNA from
Bacillus stearothermophilus into mammalian cells to site-specifically
incorporate an unnatural amino acid [8]. The final method
involves the introduction of a tRNA-aminoacyl-tRNA synthetase
pair from Methanosarcina mazei in E. coli and the shuttling of the pair
into mammalian cells, exploiting the unique promiscuity of such
pairs and the unique feature of their orthogonality [10].
In the method described here, we utilized an existing M.
jannaschii synthetase-tRNA pair evolved in E. coli, directly in
mammalian cells. The advantage of this method is that there is a
large pool of evolved E. coli synthetase-tRNA pairs for unnatural
amino acids already available, as compared to those available in
Saccharomyces cerevisiae. Our method (detailed below) renders
existing methods more accessible by making adaptation quicker
and more efficient than in yeast, for example.
Results and Discussion
To suppress the amber codon inserted into the gfp and foldon
genes introduced into mammalian cells, an orthogonal tRNA
synthetase-tRNA pair was first engineered. After the cells were
transfected with plasmids encoding this orthogonal tRNA
synthetase-tRNA pair, the cellular translation machinery inserted
tyrosine into nascent proteins in response to an encountered
amber codon within the gene encoding the proteins of interest,
namely GFP and foldon. To engineer the orthogonal tRNA
synthetase-tRNA pair for subsequent use in mammalian cells, a
‘cut and paste’ approach was utilized. Archaeal and eukaryotic
tRNA synthetase-tRNA pairs recognize each other by identity
determinants that distinguish them from bacterial tRNA synthe-
tase-tRNA pairs. The key determinant in the archaeal and
eukaryal complexes is a single base pair in the tRNA moiety which
is recognized by the connective polypeptide region (CP1) in the
corresponding tRNA synthetase. Specifically, archaeal/eukaryotic
tRNA synthetases recognize the C1:G72 base pair, while bacterial
tRNA synthetases recognize the G1:C72 base pair [11–13]. The
‘cut and paste’ approach exploits these identity determinants in
order to generate an orthogonal tRNA synthetase-tRNA pair in
mammalian cells [11,13,14]. This novel ‘cut and paste’ method
thus allows for rapid engineering of existing evolved M. jannaschii
tRNA synthetase-tRNA pairs. M. jannaschii tyrosyl tRNA synthe-
tase (TyrRS) is an ideal synthetase for such manipulation as it is
distinct from the TyrRS’s of other organisms since it only uses
information found in the tRNA
Tyr
CUA acceptor stem to identify and
bind its cognate tRNA [13]. TyrRS from most other organisms
also rely on sequence information found in the anticodon loop and
D stems [13].
Twocritical elements areexploitedin pairing M. jannaschii TyrRS
with its cognate tRNA
Tyr
CUA, namely a thirty-nine amino acid long
connective polypeptide region (CP1) in the TyrRS and a single base
pair, C1:G72, found in the acceptor stem of the tRNA
Tyr
CUA. These
elements are, however, also found in mammalian synthetases and
tRNAs, rendering the M. jannaschii TyrRS-tRNA
Tyr
CUA pair non-
orthogonal in mammalian cells [11,13]. Therefore, in order to use
M. jannaschii TyrRS and tRNA
Tyr
CUA orthogonally in a mammalian
system, these sequence elements were altered to their bacterial
versions, which are not recognized by eukaryotes (Figure 1). These
minimal manipulations had little or no effect on the amino acid
selectivity of TyrRS, since the CP1 region of TyrRS is remote from
the amino acid-binding site [12]. Next, the base pair, C1:G72 of M.
jannaschiitRNA
Tyr
CUA wasmutated toG1:C72to allowthe E. coli CP1
region in M. jannaschii TyrRS to recognize only this specific tRNA.
In order for the modified M. jannaschii tRNA
Tyr
CUA to insert tyrosines
at specificsitesinGFP,thecorrespondinganticodon wasmutated to
CUA, which recognizes its cognate codon (TAG) in mRNA
encoding for the GFP protein. Vectors with six tandemly arranged
tRNA genes, as well as with a single tRNA gene and the
corresponding 59 and 39 flanking sequences, were generated, based
on previous findings [6].
To examine whether our hypothesis regarding the CP1 region,
namely that the ‘cut and paste’ approach is significant enough to
render orthogonality between M. janaschii and mammalian cells, an
amber codon was introduced within the foldon gene at position 68.
The orthogonality of the M. jannaschii tRNA synthetase-tRNA pair
was observed via western blot. Cells from the HEK 293T cell line
were transfected with different combinations of plasmids. All of the
cells were also transfected with a plasmid harboring the 68TAG
foldon mutant. Forty eight hours following transfection, the cells
were harvested and foldon was purified, if fully expressed, via
affinity purification resin with anti-V5 antibodies. (V5 is a short
peptide that was fused to the C-terminal of foldon as an epitope
tag). Purified foldon mutants were also subjected to western blot
using anti-V5 antibodies. Lanes 1 and 3 of figure 2 it respectively
show full length foldon expressed both in the presence or the
absence of the mutant M. janaschii RS where the CP1 region was
switched to recognize the G1:C72 tRNA base pair. These results
indicate that the M. janaschii C1:G72 tRNA is aminoacylated by
endogenous RSs in the mammalian cells. However, there is hardly
any detectible mutant foldon when the mutant M. janaschii RS is
absent (lane 2), yet full length expression when it is present (lane 4).
These results are indicative of the fact that the G1:C72 tRNA was
not aminoacylated by endogenous RSs, whereas when the mutant
RS is present, the tRNA is charged with tyrosine. Further controls
demonstrated that in the absence of the mutant suppressor tRNA,
no full length foldon was observed, implying that there are no
endogenous tRNAs that are charged by the mutant M. janaschii RS
(lane5) nor that suppression spontaneously occurred within these
cells (lane 6). Hence, figure 2 confirms that the single base pair
switch in the mutant tRNA together with the CP1 switch in the
RS, are sufficient to switch the archaeal pair from being
orthogonal in bacteria to being orthogonal in eukaryotes.
Next, we wanted to confirm that the observed orthogonality was
not protein-dependent or signal-dependent. Accordingly, we
assessed the expression of a different protein. Again, HEK 293T
cells were transfected to express different combinations of plasmids
harboring the gfp gene, mutant suppressor tRNA
Tyr
CUA and mutant
TyrRS. Mutant GFP protein was encoded by a gene in which the
TAG stop codon was inserted at position 40, yielding mutant
From Archaea to Mammals
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e1126340TAGgfp. A construct including wild type gfp (wt gfp) served as a
control. The GFP protein, either mutant or wt, was fused to a
6xHis tag at its C-terminal. After transfection, cells were
monitored at 24, 48, and 72 hours by fluorescence microscopy
for the detection of GFP fluorescence. After 72 hours, pictures of
the cells were taken and are shown in the different panels of
figure 3A (panels i–v). HEK 293T cells expressed the full-length wt
GFP with an efficiency of 95% (figure 3A, panel i). However, we
did not observe fluorescence in the absence of the introduced
orthogonal pair (figure 3A, ii). When mutant tRNA and mutant
GFP were present in the HEK 293T cells, marginal (,1%)
fluorescence was detected (figure 3A, iii). The results thus suggest
that tRNA
Tyr
CUA 6 (which contains 6 consecutive copies of the
mutant tRNAs, shown in figure 1) interacts with endogenous
tRNA synthetases only to a small extent. To investigate the
orthogonality of endogenous mammalian tRNAs towards the
mutant tRNA synthetases, the mutant tRNA synthetase was
expressed together with 40TAGGFP. When mutant gfp and
mutant TyrRS were present in the HEK 293T cells (figure 3A,
panel iv), the extent of GFP fluorescence was roughly 5%, as
compared to the extent of wt GFP fluorescence. The background
signal observed in panel iv (figure 3A) is likely due to the mutant
Tyr tRNA synthetase interacting with endogenous tRNAs. Finally,
panel v displays fluorescence originating from the suppression
assay where plasmids encoding mutant GFP, mutant TyrRS, and
mutant tRNA
Tyr
CUA 6 were all introduced into the HEK 293T cells.
Since plasmid encoding for the mutant GFP was co-transfected
with plasmid encoding the newly engineered M. jannaschii TyrRS-
tRNA
Tyr
CUA pair, GFP fluorescence (panel v) was roughly 20% of
that obtained with wt GFP (panel i). While some stop codon
suppression was observed in the negative controls, our results
indicate that the ‘cut and paste’ method employed is a valid
method for suppressing amber codons in gfp. To verify full length
GFP expression, all plates were harvested at 72 hours, after which
time the cells were lysed, GFP protein was purified and examined
Figure 2. The orthogonality of the M. jannaschii TyrRS-tRNA
Tyr
CUA
pair was verified on western blots probed with anti-V5
antibodies. Expression of full-length foldon was monitored when
various tRNAs were introduced into the HEK 293T cells. Note that the
tRNA mutants used in these experiments were slightly different from
those depicted in figure 1.
doi:10.1371/journal.pone.0011263.g002
Figure 1. ‘Cut and Paste’ approach used to construct an orthogonal M. jannaschii tRNA synthetase-tRNA pair for use in mammalian
cells. (A) The M. jannaschii tRNA synthetase (RS) CP1 region (red) was replaced with the E. coli RS CP1 region (blue) to create mutant M. jannaschii RS
CP1. (B) The mutations in the M. jannaschii tyrosyl tRNA mutant are shown in red.
doi:10.1371/journal.pone.0011263.g001
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strong band of 28 kDa was detected, corresponding to the
expression of wt GFP (lane 1). Negative controls using either
mutant tRNA
Tyr
CUA 6 or mutant TyrRS designed to assay
orthogonality either yielded no antibody-stained band (lane 2) or
only a faint band (lane 3), since no more than 5% of full-length
GFP was detected in the corresponding fluorescence image
(figure 3A, iii and iv respectively) under these conditions. Although
a peptide from the N-terminus of GFP (4.4 kDa) is likely to be
expressed in the negative control (lane 2), the truncated GFP
products are not detected by the western blot because the 6xHis
epitope is located at the C-terminal of the protein. When one
considers band observed in lane 4 it is clear that suppression of the
amber codon in GFP is clearly stimulated (,20% efficiency),
relative to the negative controls containing either mutant
tRNA
Tyr
CUA 6 or mutant TyrRS. The 20% tyrosine suppression
efficiency observed is similar to what has been reported elsewhere,
where 20–40% suppression efficiency were typically achieved
[15–17]. The data shown in figure 3 confirm our hypothesis that
‘cut and paste’ of the CP1 region within the tRNA synthetase is a
valid method to rapidly engineer M. jannaschii TyrRS-tRNA
Tyr
CUA
pairs designed to fit into mammalian systems. Our study also
provides the first in vivo evidence of discrimination in the CP1
region and the G1:C72 or C1:G72 recognition sequence in
cognate tRNAs along kingdom lines.
Conclusions
In conclusion, we have demonstrated that the novel method-
ology introduced here can be readily applied to the plethora of
extant evolved E. coli synthetase-tRNA pairs by introducing a few
minor changes into the tRNA and synthetase gene sequences. This
methodology can thus be used for the incorporation of unnatural
amino acids into mammalian proteins, thereby aiding in the study
of protein structure and function.
Materials and Methods
Strains and Enzymes
Chemically competent E. coli TOP10 cells were used for
propagation and isolation of all plasmids. Human embryonic
kidney 293T (HEK 293T) cells were used for genetic assays. All
enzymes were obtained from New England Biolabs (Ipswich, MA),
unless otherwise stated.
Plasmid Construction
DNA encoding wild type (wt) M. jannaschii tyrosine-tRNA
synthetase (MjTyrRS) was amplified by polymerase chain reaction
(PCR) and cloned into plasmid pEF6-V5-His6-TOPO (Invitogen,
Carlsbad, CA) according to the supplier’s instructions. The
connective polypeptide 1 (CP1) region (amino acids 110–148) of
MjTyrRS was replaced with the CP1 region of E. coli TyrRS
(amino acids 110–172). Briefly, the 59 region of MjTyrRS was
amplified using PCR with the primers, EYRS1-topBamH1, (bold
letters represent restriction sites) (59-AAGGATCCACCATG-
GACGAATTTGAAATGAT-39) and EYRS1-bot (59-ACATT-
CATATTGCCGAACCACTGGAATTCACTTCCAT-39). The
39 region of MjTyrRS was PCR amplified using the primers,
EYRS3-top (59-AGGGGATTTCGTTCACTGAGGTTATCT-
Figure 3. Suppression of an amber codon inserted into the GFP-encoding gene. (A) Full-length GFP was expressed in HEK 293T cells only in
the presence of a M. jannaschii TyrRS-tRNA
Tyr
CUA pair designed to be orthogonal to mammalian cells. (B) Western blot analysis of full-length GFP
probed with anti-His antibodies.
doi:10.1371/journal.pone.0011263.g003
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TTCTAATCTCTTTCTAATTGGCT-39). The E. coli CP1
region was PCR amplified from the E. coli TyrRS using primers
EYRS2-top (59-ATGGAAGTGAATTCCAGTG GTTC GGCA-
ATATGAATGT-39) and EYRS2-bot (59-TGCATTATTGGA-
TAGATAACTTCAGTGAACGAAATCCCCT-39). The result-
ing three PCR fragments (i.e. M. jannaschii 59 and 39 regions, and
E. coli CP1 region, 1 mg each) were combined, denatured for
15 minutes at 85uC, and elongated at room temperature with
Klenow enzyme for 30 minutes, according to the product manual.
The Klenow product was PCR amplified using EYRS1-
topBAMH1 and EYRS3-botEcoR1 primers to create the full-
length M. jannaschii TyrRS CP1 mutant. The mutant TyrRS gene
and the pEF6/V5 vector (Invitrogen, Carlsbad, CA) were digested
with HindIII and EcoRI and the digested products were ligated to
yield plasmid pMUTyrRS.
To generate the desired amber suppressor, tRNA
Tyr
CUA,i n
mammalian cells, overlapping oligonucleotides (restriction sites are
in bold) (AACTGCAGAGCGCTCCGGTTTTTCTGTGCTGA-
ACCTCAGGGGACGCCGACACACGTACACGTCGCGGCG-
GTAGTTCAGCCTGGTAGAACGGCGGACTCTAAATCCG-
CATG) and (CCGCTCGAGTAGATAATTTATAATAAATG-
GTGCGGCGGGCCGGATTTGAACCAGCGACATGCGGAT-
TTAGAGTCCGCCGTTCTACCA) were designed for the M.
jannaschii tRNA
Tyr sequence with a few modifications. These
modifications included altering C1:G72 in the acceptor stem to
G1:C72, altering the Tyr anticodon (GUA) to recognize the amber
stop codon (CUA), and mutation G38 to A38. In addition, the
human tRNA
Tyr 59-flanking sequence (AGCGCTCCGGTTT-
TTCTGTGCTGAACCTCAGGGGACGCCGACACACGTAC-
ACGTC) and a 39-thymine (T)-rich flanking sequence (TTTATTA-
TAAATTATCTA) were added to the M. jannaschii tRNA
Tyr.T h e
oligonucleotides were annealed and elongated with Klenow
polymerase, as described above. The mutant sequence was amplified
by PCR, digested overnight with PstI and XhoI, and ligated with T4
DNAligaseintothePstIandXhoIpre-digestedplasmid,pZeoSV2(+)
(Invitrogen, Carlsbad, CA), to yield pMU tRNA
Tyr
CUA.T h i sp l a s m i d
was then used as a template for the six unidirectional copy gene
cluster. To generate the cluster, mutant M. jannaschii tRNA was first
amplified by PCR with primers KpnI 1-1 Fwd (GGGGTAC-
CAGCGCTCCGGTTTTTCTGTG) and KpnI 1-1 Rev (GGGG-
TACCTAGATAATTTATAATAAATGGTGCGGCGGG).T h e
PCR product, i.e. mutant M. jannaschii tRNA
Tyr
CUA, was digested
with KpnI overnight, purified with a QIAprep Miniprep Kit
according to the manufacturer’s instructions (Qiagen, Valencia,
CA), and ligated with T4 DNA ligase into the KpnI pre-digested
pMU tRNA
Tyr
CUA plasmid to yield plasmid pMU tRNA
Tyr
CUA 2. The
M. jannaschii tRNA single copy mutant was PCR amplified with
primers EcoRI 1-1 Fwd (GGAATTCAGCGCTCCGGTT-
TTTCTGTG) and EcoRI 1-1 Rev (GGAATTCTAGATAAATT-
TATAATAAATGGTGCGGCGGG). The resulting PCR product
was digested with EcoRI overnight and purified with the QIAprep
Miniprep Kit. The purified and digested PCR product was ligated in
the EcoRI site of plasmid pMU tRNA
Tyr
CUA 2w i t hT 4D N Al i g a s et o
yield plasmid pMU tRNA
Tyr
CUA 3. Finally, the three copy mutant M.
jannaschii tRNA
Tyr
CUA was PCR amplified from plasmid pMU
tRNA
Tyr
CUA 3 using primers NheI 1-1-3 Fwd (GGGGCTAGCT-
TAAGCTTGGTACCAGCGC) and HindIII 1-1-3 Rev (GGG-
AAGCTTGGGCCCTCTAGACTCGAG).T h et R N Aw a sd i g e s t -
ed with NheI and HindIII overnight, purified with the QIAprep
Miniprep, and ligated with T4 DNA ligase into pre-digested plasmid
pMU tRNA
Tyr
CUA 3 to generate plasmid pMU tRNA
Tyr
CUA 6. The
correct construction of plasmid pMU tRNA
Tyr
CUA 6 was confirmed by
DNA sequencing (University of Texas Core Facility).
The codon for Tyr40 of the green fluorescent protein (GFP)
gene under control of a CMV promoter in a mammalian
expression vector (pLit) was mutated to an amber codon (TAG)
using the Quikchange II Site-Directed Mutagenesis Kit (Strata-
gene, La Jolla, CA), as directed. The identity of the resulting
p40TAGGFP plasmid was confirmed by DNA sequencing
(University of Texas Core Facility).
The pFoldon plasmid, which was used to express the
bacteriophage T4 fibritin (foldon) domain in HEK 293T cells,
was constructed by inserting the PCR-amplified gene fragment
into the pCDA3.1-V5-His-TOPO vector (Invitrogen, Carlsbad,
CA). Plasmid pFoldonTAG, which encodes the Trp68TAGfoldon
mutant, was constructed by site directed mutagenesis by using the
QuikChangeXL (Staratagene, La Jolla, CA) method and the
corresponding HPLC-purified primers.
Cell Culture and Transfections
HEK 293T cells ATCCH CRL-11268
TM were cultured in
Dulbecco’s Modified Eagle Medium (D-MEM) high glucose
(Invitrogen, Carlsbad, CA) supplemented with 10% (v/v) heat-
inactivated Fetal Bovine Serum (FBS) Premium Select, Lot #
C0136 (Atlanta Biologicals, Lawrenceville, GA) and 1% penicillin-
streptomycin (HyClone, Logan, UT) at 37uC in a humidified
incubator containing 5% CO2. Transfections were performed at
70–80% confluency in a 100-mm plate (Corning, Corning, NY)
using FuGENE 6 (Lot # 93576920; Roche, Indianapolis, IN). The
pMUTyrRS, pMU tRNA
Tyr
CUA 6, and p40TAGGFP or pFoldon-
TAG constructs were transiently transfected into HEK 293T cells,
as described in the FuGENE 6 manual. Full-length GFP was
excited at 460–500 nm and detected in the cells by monitoring
emission wavelength (510–560 nm) using a Nikon Eclipse
TE2000-S microscope equipped with a FITC HyQ filter
(Chroma, Rockingham, VT). Negative controls lacking each of
the aforementioned constructs, and positive controls transfected to
express wild type GFP were also simultaneously generated. All
genetic experiments were performed in triplicate.
Harvest and Lysis of HEK 293T cells
The mammalian plasmids p40TAGGFP and pLit harboring the
gene that encodes GFP containing a 6x-histidine tag to facilitate
protein purification. Plasmid pFoldonTAG harbors the foldon gene
and encodes for a V5 peptide tag to facilitate its affinity
purification using an anti-V5 antibody-bearing agarose affinity
gel (Sigma, Saint Louis, MO). The HEK 293T cells were
harvested in 16PBS, after being physically scraped from growth
plates and centrifuged at 10006g. The collected cells were re-
suspended in 2.56 passive lysis buffer (Promega, Madison, WI)
supplemented with a Complete Mini-Protease inhibitor tablet
(Roche), and incubated on ice for 30 minutes. The lysed cells were
centrifuged to collect the soluble protein fraction, which was
subsequently visualized by western blot.
Western Blots
Full-length mammalian-derived GFP or foldon found in the
supernatant collected above were separated by 12% sodium
dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto an Immobilon PVDF membrane (Millipore,
Billerica, MA) in transfer buffer (48 mM Tris, 39 mM glycine,
20% methanol (v/v), pH 9.2) using a BioRad Semi-Dry Blotter.
The membrane was then probed with anti-V5 C-terminal primary
antibodies (Invitrogen, Carlsbad, CA) and a goat anti-mouse
alkaline phosphatase conjugated secondary antibodies (BioRad,
Hercules, CA) or with anti 6xHis C-terminal antibodies (Invitro-
gen, Carlsbad, CA). The bands were visualized with a chemilu-
From Archaea to Mammals
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Kodak BioMax Light Film. The western blots experiments were
repeated no less than three times.
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